Harbour Investments’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$162K Buy
1,080
+1,008
+1,400% +$110K ﹤0.01% 1716
2026
Q1
$6.66K Sell
72
-4
-5% -$402 ﹤0.01% 3468
2025
Q4
$7.76K Buy
76
+65
+591% +$5.82K ﹤0.01% 2861
2025
Q3
$687 Hold
11
﹤0.01% 3468
2025
Q2
$572 Hold
11
﹤0.01% 3352
2025
Q1
$469 Hold
11
﹤0.01% 3347
2024
Q4
$336 Hold
11
﹤0.01% 3328
2024
Q3
$252 Hold
11
﹤0.01% 3265
2024
Q2
$318 Hold
11
﹤0.01% 3129
2024
Q1
$227 Hold
11
﹤0.01% 3104
2023
Q4
$298 Sell
11
-400
-97% -$10.5K ﹤0.01% 2991
2023
Q3
$12.2K Hold
411
﹤0.01% 1956
2023
Q2
$14.7K Hold
411
﹤0.01% 1890
2023
Q1
$9.63K Sell
411
-15
-4% -$428 ﹤0.01% 2024
2022
Q4
$11.6K Buy
426
+11
+3% +$503 ﹤0.01% 1897
2022
Q3
$17K Hold
415
﹤0.01% 1729
2022
Q2
$17K Buy
+415
New +$20.6K ﹤0.01% 1729
2021
Q4
$43K Sell
431
-443
-51% -$45.8K ﹤0.01% 1323
2021
Q3
$109K Buy
874
+15
+2% +$1.78K ﹤0.01% 1327
2021
Q2
$107K Sell
859
-1,366
-61% -$184K ﹤0.01% 1366
2021
Q1
$340K Buy
+2,225
New +$336K 0.01% 754

Other funds holding GH

Harbour Investments's GH Position: Q2 2026 in Review

Harbour Investments increased its Guardant Health (GH) stake by 1,400% in Q2 2026, buying an estimated $110K and bringing the position to 1,080 shares worth $162K. The position accounts for ﹤0.01% of the portfolio, ranked #1716.

Harbour Investments first reported a position in GH in Q1 2021 and has held it in 21 quarters since. The position peaked at $340K in Q1 2021. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Harbour Investments held 1,080 shares of Guardant Health worth $162K as of Q2 2026.
  • Harbour Investments bought 1,008 Guardant Health shares in Q2 2026, an estimated $110K.
  • Guardant Health made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #1716 holding.
  • Harbour Investments first reported a position in Guardant Health in Q1 2021 and has held it in 21 quarters since.
  • Harbour Investments's Guardant Health position peaked at $340K in Q1 2021.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.